Premenopausal determinants of menopausal estrogen use

Area of Science:

• Reproductive Endocrinology
• Menopause Research
• Hormone Therapy Studies

Background:

• Menopausal hormone therapy (MHT) is widely used for symptom management.
• Understanding baseline characteristics of MHT users is crucial for interpreting health outcomes.
• Previous research has not fully elucidated premenopausal predictors of MHT initiation.

Purpose of the Study:

• To prospectively evaluate premenopausal characteristics associated with the subsequent use of estrogen replacement therapy (ERT).
• To identify baseline differences between women who initiate menopausal ERT and those who do not.
• To inform clinical understanding of patient selection for hormone therapy.

Main Methods:

• Prospective cohort study design.
• Inclusion of 541 healthy premenopausal women.
• Follow-up through the menopausal transition to assess ERT use.

Main Results:

• Menopausal ERT users were significantly more likely to be leaner and report prior oral contraceptive use compared to never users (P ≤ 0.05).
• Trends indicated ERT users had higher high-density lipoprotein cholesterol and lower fasting insulin pre-therapy (P ≤ 0.10).
• Weaker trends showed ERT users consumed more alcohol, expended more calories, and had lower blood pressure pre-therapy.

Conclusions:

• The findings suggest that women who choose menopausal hormone therapy may possess a slightly healthier baseline profile.
• These results do not negate the potential benefits of ERT for coronary heart disease.
• Further research is needed to understand the interplay between baseline health and MHT initiation.